Immunization against Medically Important Human Coronaviruses of Public Health Concern

Author:

Nimer Nabil A.ORCID,Nimer Seema N.ORCID

Abstract

SARS‐CoV‐2 is a virus that affects the human immune system. It was observed to be on the rise since the beginning of 2020 and turned into a life‐threatening pandemic. Scientists have tried to develop a possible preventive and therapeutic drug against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) and other related coronaviruses by assessing COVID‐19‐recovered persons’ immunity. This study aims to review immunization against SARS‐CoV‐2, along with exploring the interventions that have been developed for the prevention of SARS‐CoV‐2. This study also highlighted the role of phototherapy in treating SARS‐CoV infection. The study adopted a review approach to gathering the information available and the progress that has been made in the treatment and prevention of COVID‐19. Various vaccinations, including nucleotide, subunit, and vector‐based vaccines, as well as attenuated and inactivated forms that have already been shown to have prophylactic efficacy against the Middle East respiratory syndrome coronavirus (MERS‐CoV) and SARS‐CoV, have been summarized. Neutralizing and non‐neutralizing antibodies are all associated with viral infections. Because there is no specific antiviral vaccine or therapies for coronaviruses, the main treatment strategy is supportive care, which is reinforced by combining broad‐spectrum antivirals, convalescent plasma, and corticosteroids. COVID‐19 has been a challenge to keep reconsidering the usual approaches to regulatory evaluation as a result of getting mixed and complicated findings on the vaccines, as well as licensing procedures. However, it is observed that medicinal herbs also play an important role in treating infection of the upper respiratory tract, the principal symptom of SARS‐CoV due to their natural bioactive composite. However, some Traditional Chinese Medicines contain mutagens and nephrotoxins and the toxicological properties of the majority of Chinese herbal remedies are unknown. Therefore, to treat the COVID‐19 infection along with conventional treatment, it is recommended that herb‐drug interaction be examined thoroughly.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3